Evenflo Breast Pump Electrical Shocks Not Properly Investigated: FDA

The FDA has sent baby product maker Evenflo a warning letter for failing to investigate reports that some women received electric shocks while using its “Comfort Select” breast pumps.

The warning letter comes after an inspection of two Ohio plants in January, where FDA inspectors found that Evenflo has failed to establish required medical device reporting procedures for its breast pumps. The FDA says in the letter, sent August 25 and released on Tuesday, that it reviewed 37 complaints of breast pump problems and found that 18 of those complaints were never investigated by the company. At least three of those complaints were from women who reported receiving Evenflo breast pump shocks.

The FDA said it found a number of current good manufacturing practices problems at plants in Miamisburg and Piqua, Ohio. Besides not fully investigating all customer complaints, the FDA said the company was failing to validate that corrective actions it took to address problems actually worked, and did not verify that corrections to products did not adversely affect those products.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The letter notes that in the months since the inspections, Evenflo has made an effort to correct all of the problems, and has done an adequate job of addressing most of them. However, the agency still appears to have some concern over Comfort Select breast pumps sold prior to December 2008, noting that the company has failed to address concerns about those devices.

The FDA also says the company still needs to develop medical device reporting (MDR) procedures for its breast pumps that identify, evaluate and report complaints that might be subject to federal MDR requirements.

Evenflo has 15 days to respond to the letter or it could face fines or other penalties.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Plaintiffs Oppose Phased Discovery Over Suboxone Tooth Decay Risks in MDL
Plaintiffs Oppose Phased Discovery Over Suboxone Tooth Decay Risks in MDL (Posted today)

Plaintiffs say a federal judge should not waste time on a phased discovery plan requiring them to first prove Suboxone strips can cause tooth decay, saying the science is obvious and such a plan could delay resolution of hundreds of product liability lawsuits.